Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus.
Eisenbach
C
C
Neumann-Haefelin
C
C
Freyse
A
A
Korsukéwitz
T
T
Hoyler
B
B
Stremmel
W
W
Thimme
R
R
Encke
J
J
D000328:Adult; D000917:Antibody Formation / Q000276:immunology*; D016174:Hepacivirus / Q000276:immunology*; D006801:Humans; D007371:Interferon-gamma / Q000097:blood; D018417:Th1 Cells / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology*; D014615:Vaccinia / Q000276:immunology* / Q000821:virology; D014616:Vaccinia virus / Q000276:immunology*; D014761:Viral Hepatitis Vaccines / Q000009:adverse effects / Q000276:immunology*; D017361:Viral Nonstructural Proteins / Q000276:immunology*; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
D007371:Interferon-gamma; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; D017361:Viral Nonstructural Proteins; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases